Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders
- 1 January 2013
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 9 (1), 30-38
- https://doi.org/10.1016/j.jalz.2012.11.002
Abstract
Managing comorbidities has been a long-standing challenge in the care of patients with Alzheimer's disease and related disorders (ADRD). Compared with individuals without dementia, Medicare beneficiaries with ADRD are more likely to be hospitalized, have longer hospital stays, and incur higher expenditures for their comorbidities [ [1] , [2] , [3] , [4] ]. Further, hospital admissions represent the largest component of healthcare expenditures for individuals with ADRD [ [5] , [6] ] and constitute more than half of total expenditures among the most expensive patients with prominent comorbidities [ 7 ] [7] . Additional time spent in the hospital also increases suffering and the risk of adverse events. Therefore, reducing unnecessary admissions is clearly an important and underserved need in ADRD care.Funding Information
- Pfizer
- Tufts Medical Center
This publication has 28 references indexed in Scilit:
- Association of Incident Dementia With HospitalizationsJAMA, 2012
- The Concentration and Persistence of Health Care Expenditures and Prescription Drug Expenditures in Medicare Beneficiaries With Alzheimer Disease and Related DementiasMedical Care, 2009
- Healthcare costs and utilization for Medicare beneficiaries with Alzheimer'sBMC Health Services Research, 2008
- Clinical features associated with costs in early ADNeurology, 2006
- Vulnerable populations at risk of potentially avoidable hospitalizations: The case of nursing home residents with Alzheimer's diseaseAmerican Journal of Alzheimer's Disease and Other Dementias®, 2005
- The Relationship Between a Dementia Diagnosis, Chronic Illness, Medicare Expenditures, and Hospital UseJournal of the American Geriatrics Society, 2004
- Alzheimer Disease in the US PopulationArchives of Neurology, 2003
- Effect of Alzheimer Disease on the Cost of Treating Other DiseasesAlzheimer Disease & Associated Disorders, 2002
- Alzheimer’s disease and related dementias increase costs of comorbidities in managed MedicareNeurology, 2002
- Alzheimer's Disease Under Managed Care: Implications from Medicare Utilization and Expenditure PatternsJournal of the American Geriatrics Society, 1998